Cargando…

Cardiac Alterations in Patients with Familial Lipodystrophy

Familial lipodystrophy is a rare genetic condition in which individuals have, besides metabolic changes and body fat deposits, a type of cardiomyopathy that has not been well studied. Many of the patients develop cardiovascular changes, the most commonly reported in the literature being the expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romano, Minna Moreira Dias, Chacon, Paula Ananda Inês, Ramalho, Fernanda Naira Zambelli, Foss, Maria Cristina, Schmidt, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077563/ https://www.ncbi.nlm.nih.gov/pubmed/32215503 http://dx.doi.org/10.36660/abc.20190016

Ejemplares similares

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

Body fat distribution in women with familial partial lipodystrophy caused by mutation in the lamin A/C gene
por: Monteiro, Luciana Z., et al.
Publicado: (2012)

PSUN138 Demonstration of Progressive Beta-Cell Failure in Familial Partial Lipodystrophy
por: De Freitas, Maria Foss, et al.
Publicado: (2022)

Evaluation of epicardial adipose tissue in familial partial lipodystrophy
por: Godoy-Matos, Amélio Fernando, et al.
Publicado: (2015)

Untangling the Heterogeneity of Acquired Generalized Lipodystrophy
por: Cavdar, Umit, et al.
Publicado: (2021)

SAT-622 Heterogeneity of Familial Partial Lipodystrophy Type 2 from a Genotype-Phenotype Perspective
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2020)

Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

Haemoglobinopathies from the cardiac point of view
por: Romano, Minna Moreira Dias
Publicado: (2019)

Body Composition And Bone Mineral Differences According to Lamin A (LMNA) Genotype in Familial Partial Lipodystrophy Type 2
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type
por: Foss-Freitas, Maria C., et al.
Publicado: (2018)

Cardiac Manifestations of Congenital Generalized Lipodystrophy
por: Sanon, Vani P., et al.
Publicado: (2016)

Abnormal Non Esterified Fatty Acid Suppression After a Mixed Meal Test in Patients With Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020)

Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy
por: Araújo, Camilla O. D., et al.
Publicado: (2021)

OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy
por: Akinci, Baris, et al.
Publicado: (2020)

The acromegaly lipodystrophy
por: Freda, Pamela U.
Publicado: (2022)

Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy
por: Domingo, Pere, et al.
Publicado: (2022)

Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning
por: Pellegrini, Camilla, et al.
Publicado: (2019)

Accelerated epigenetic aging and DNA methylation alterations in Berardinelli–Seip congenital lipodystrophy
por: Qannan, Abeer, et al.
Publicado: (2023)

Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy
por: Godoy-Matos, Amelio F., et al.
Publicado: (2018)

Leptin Improves Cardiac Structure and Function in Patients With Generalized Lipodystrophy
por: Nguyen, My-Le, et al.
Publicado: (2021)

Influence of Galectin-3 on the Innate Immune Response during Experimental Cryptococcosis
por: Rezende, Caroline Patini, et al.
Publicado: (2021)

Hepatic Steatosis Resulting From LMNA-Associated Familial Lipodystrophy
por: Mahdi, Layth, et al.
Publicado: (2020)

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)

Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2
por: Corsa, Callie A.S., et al.
Publicado: (2021)

Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis
por: Cook, Keziah, et al.
Publicado: (2021)

Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
por: Foss-Freitas, Maria C., et al.
Publicado: (2021)

Treatment Options for Lipodystrophy in Children
por: Mainieri, Francesca, et al.
Publicado: (2022)

Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations
por: Subauste, Angela R., et al.
Publicado: (2012)

Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
por: Cui, Ying, et al.
Publicado: (2022)

Evaluation of the hypothalamic–pituitary–adrenal axis in a case series of familial partial lipodystrophy
por: Elias, Cecília Pacheco, et al.
Publicado: (2019)

Insulin lipodystrophy and lipohypertrophy
por: Mokta, Jatinder K., et al.
Publicado: (2013)

Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013)

SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy
por: Madeira, Mayara Ponte, et al.
Publicado: (2021)

Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic
por: Iwanishi, Masanori, et al.
Publicado: (2018)

SAT-617 Potential Utility of the Mixed Meal Test for Differential Diagnosis of Partial Lipodystrophy from Common Type 2 Diabetes and Truncal Obesity
por: Guraya, Armaan, et al.
Publicado: (2020)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

MON-121 Pain Is a Major Driver of Quality of Life and Psychoemotional Health in Lipodystrophy Syndromes
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

Familial Partial Lipodystrophy: A Case Study and Review of Recent Literature
por: Tipu, Ali, et al.
Publicado: (2021)

Targeted Therapeutic Approach in Patients With Familial Partial Lipodystrophy Type 3
por: Cohen, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqtjveurllnk557ij72psr4rm3